UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 20, 2021
| ADVANCED BIOENERGY, LLC | ||||
| (Exact name of Registrant as Specified in Charter) | ||||
| Delaware | ||||
| (State or Other Jurisdiction of Incorporation) | ||||
| 000-52421 | 20-2281511 | |||
| (Commission File Number) | (I.R.S. Employer Identification No.) | |||
| Box 201759 Bloomington, Minnesota | 55420 | |||
| (Address of Principal Executive Offices) | (Zip Code) | |||
| Registrant’s Telephone Number, Including Area Code: None | ||||
Securities registered pursuant to Section 12(b) of the Act: None
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 8.01. | Other Events. |
Beginning on or about July 20, 2021, Advanced BioEnergy, LLC, (the “Company”) sent a letter to its Members updating them of the status of its Liquidation and Dissolution. Each Member was also sent a final distribution check for $0.332 per unit, or approximately $8.5 million in aggregate, for the 25,610,851 ABE units outstanding. A copy of the Member letter is attached as Exhibit 99.1.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
The Following is filed as an exhibit to this Report:
| Exhibit No. | Description of Exhibit | |
| 99.1 | Advanced BioEnergy, LLC July 2021 Letter to Members |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ADVANCED BIOENERGY, LLC | |||
| By: | /s/ J.D. Schlieman | ||
| J.D. Schlieman, Continuing Director | |||
Date: July 26, 2021
2